(PHRM) Phorm Inc
Summary
Trade long or short on this share now through an Interactive Investor Spread Bet or CFD
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 6517U Phorm Inc 28 December 2011 28 December 2011 Phorm, Inc. ("Phorm" or the "Company") Director Dealing
Phorm (AIM: PHRM and PHRX) announces that on December 28th Kent Ertugrul, CEO and Chairman of the Company, transferred for nil consideration 2,594,412 shares in the Company to Value Trust Holdings Pte Ltd limited for tax planning purposes.
For Enquiries
Phorm, Inc. Andy Croxson (analysts & investors) +44 20 7297 2326 Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500 (Nominated Advisor) Simon Bridges, Andrew Chubb This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 7763T Phorm Inc 12 December 2011 12 December 2011
Phorm, Inc. ("Phorm" or the "Company")
Transfer of Shares
Phorm, Inc., (AIM: PHRX and PHRM), today announces that the Company has applied to AIM for the following shares to be transferred from the unrestricted line, trading under PHRX, to the restricted line, trading under PHRM.
Description of Security Old Ticker Symbol New Ticker Symbol No. of Shares ----------------------------- ------------------------ ------------------------- ----------------- Common Shares of $0.001 each PHRX PHRM 733
Following the transfer of these shares the Company still has a total of 75,491,515 issued and outstanding Common Shares trading on AIM, of which 74,682,990 will be in the restricted line, trading under PHRM, and 808,525 in the unrestricted line, trading under PHRX. 45,000 of the aforementioned PHRM Common Shares are held in treasury.
No new shares have been issued and dealings in the shares under the new ticker symbols are expected to commence on 13 December 2011.
For Enquiries
Phorm, Inc. Andy Croxson (analysts & investors) +44 20 7297 2326 Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500 (Nominated Advisor) Simon Bridges, Andrew Chubb - ends - This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 07-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 5131T Phorm Inc 07 December 2011 7 December 2011
Phorm, Inc. ("Phorm" or the "Company")
Transfer of Shares
Phorm, Inc., (AIM: PHRX and PHRM), today announces that the Company has applied to AIM for the following shares to be transferred from the unrestricted line, trading under PHRX, to the restricted line, trading under PHRM.
Description of Security Old Ticker Symbol New Ticker Symbol No. of Shares ----------------------------- ------------------------ ------------------------- ----------------- Common Shares of $0.001 each PHRX PHRM 24,693
Following the transfer of these shares the Company still has a total of 75,491,515 issued and outstanding Common Shares trading on AIM, of which 74,682,257 will be in the restricted line, trading under PHRM, and 809,258 in the unrestricted line, trading under PHRX. 45,000 of the aforementioned PHRM Common Shares are held in treasury.
No new shares have been issued and dealings in the shares under the new ticker symbols are expected to commence on 8 December 2011.
For Enquiries
Phorm, Inc. Andy Croxson (analysts & investors) +44 20 7297 2326 Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500 (Nominated Advisor) Simon Bridges, Andrew Chubb - ends - This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 02-12-11 | RNS |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
RNS Number : 2766T Phorm Inc 02 December 2011
This information is provided by RNS The company news service from the London Stock Exchange More |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
Glenstrata's just a silly word. Stick to big dividendsEditor's Pick:
Bulls should head for ChinaEditor's Pick:
Stock to Watch: Imperial TobaccoEditor's Pick:
George Godber’s AIM stock picks

